LivaNova LIVN
NASDAQ LIVN
$78.00 -2.84 (-3.51%)
At close: Aug 20, 2026 · 1:33 PM UTC

LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026)

LivaNova (LIVN) posted Non-Current Deferred Tax Liability of $6.8 million for Q1 2026, down 28.97% sequentially from $9.6 million in Q4 2025, and down 35.89% YoY from $10.6 million in Q1 2025.

LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends

LivaNova has reported Non-Current Deferred Tax Liability for 12 years, with the latest figure at $6.8 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability fell 35.89% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 35.89% YoY) and the FY2025 annual result came in at $9.6 million, down 85.25% from the prior year.
  • Non-Current Deferred Tax Liability eased to $6.8 million in Q1 2026 per LIVN's latest filing, from $9.6 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $89.2 million in Q4 2022 and troughed at $6.5 million in Q3 2022.
  • A 5-year average of $20.5 million and a median of $10.1 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability surged 1054.62% in 2022, then tumbled 85.25% in 2025.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $89.2 million in 2022, then tumbled by 30.34% to $62.2 million in 2023, then grew by 4.62% to $65.0 million in 2024, then sank by 85.25% to $9.6 million in 2025, then decreased by 28.97% to $6.8 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.8 million, $9.6 million, and $10.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.91 Bn 193.31 Bn 7.27 Bn
2 Stryker 127.59 Bn 124.11 Bn 4.50 Bn
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn
4 Boston Scientific 73.24 Bn 72.70 Bn 3.85 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn
6 Dexcom 34.38 Bn 32.44 Bn 830.00 Mn
7 GE HealthCare Technologies 33.96 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.08 Bn 22.60 Bn 684.20 Mn
10 LivaNova 4.29 Bn 3.77 Bn 273.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.31 Mn
Jun 30, 2026 9.31 Mn
Mar 31, 2026 6.81 Mn
Mar 31, 2026 6.81 Mn
Dec 31, 2025 9.59 Mn
Dec 31, 2025 9.59 Mn
Sep 30, 2025 10.10 Mn
Sep 30, 2025 10.10 Mn
Jun 30, 2025 11.39 Mn
Jun 30, 2025 11.39 Mn
Mar 31, 2025 10.63 Mn
Mar 31, 2025 10.63 Mn
Dec 31, 2024 65.03 Mn
Dec 31, 2024 65.03 Mn
Sep 30, 2024 11.84 Mn
Sep 30, 2024 11.84 Mn
Jun 30, 2024 10.84 Mn
Jun 30, 2024 10.84 Mn
Mar 31, 2024 10.97 Mn
Mar 31, 2024 10.97 Mn